|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.485 HKD | +0.24% |
|
+2.23% | +0.65% |
| 07:35am | CSPC Pharma Unit, Alphamab Oncology's Breast Cancer Drug Application Granted Priority Review in China | MT |
| Aug. 03 | CSPC Pharma Begins Phase Ib/II Trial of Colorectal Cancer Drug Candidate | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 8.76 | 10.69 | 8.59 |
| Spread/Res. | -3.14% | -20.63% | -1.22% |
| Spread/Supp. | +8.23% | +27.59% | +26.83% |
| Support | 7.84 | 6.65 | 6.69 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 1093 Stock
- Charts CSPC Pharmaceutical Group Limited
Select your edition
All financial news and data tailored to specific country editions
